After data-mining for GSTM5 and bladder cancer in cancer vs. normal differential analysis (p < 0.001, fold change >1.5, gene rank the top 10%), three mRNA databases exhibited differential expression (Sanchez-Carbayo bladder 2, Lee bladder and Dyrskjot bladder 3). This evidence concerns the gene GSTM5 and urinary bladder cancer.